BAC — Camsing Healthcare Income Statement
0.000.00%
Last trade - 00:00
- SG$12.60m
- SG$20.24m
- SG$4.85m
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.31 | 5.69 | 5.53 | 6.1 | 4.85 |
Cost of Revenue | |||||
Gross Profit | 4.27 | 3.38 | 2.83 | 3.51 | 2.98 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12.8 | 6.52 | 6.88 | 8.51 | 7.58 |
Operating Profit | -5.46 | -0.829 | -1.35 | -2.4 | -2.72 |
Net Income Before Taxes | -5.46 | -0.829 | -1.35 | -2.4 | -2.72 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.46 | -0.829 | -1.33 | -2.4 | -2.72 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -5.46 | -0.828 | -1.33 | -2.4 | -2.72 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.46 | -0.828 | -1.33 | -2.4 | -2.72 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.141 | -0.054 | -0.044 | -0.083 | -0.085 |